Advertisement
Document › Details
Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg.
Region | EU (European Union) | |
Organisation | Pentixapharm Holding AG (FSE Prime Standard: PTP) | |
Today | Pentixapharm (Group) | |
Group | Pentixapharm (Group) | |
Organisation 2 | EMA (European Medicines Agency) | |
Group | EU (govt) | |
Product | PentixaFor (gallium-68-based companion diagnostic) | |
Product 2 | positron emission tomography (PET) | |
Person | Riehle, Karolin (Eckert & Ziegler 202212 Investor Relations + PR) | |
Person 2 | Hennecke, Anne (MC Services 201211 Managing Partner before Evotec + Schwarz Pharma) | |
[Not for US, AU, CA, JP, ZA, et al.]
Record changed: 2024-09-29 |
Advertisement
More documents for Pentixapharm (Group)
- [1] |transkript [Kääb, Georg]. (9/24/24). "First German Life Sciences IPO since 2016 – Radiopharma Company Pentixapharm Lists at Frankfurt Stock Exchange. Interview by |transkript.de/Georg Kääb with Andreas Eckert"....
- [2] Pentixapharm Holding AG. (9/23/24). "Press Release: Pentixapharm Holding AG Sets Price Range for Planned IPO [Not for US, AU, CA, JP, ZA, et al.]". Berlin & Würzburg....
- [3] Pentixapharm Holding AG. (9/12/24). "Press Release: Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange [Not for US, AU, CA, JP, ZA, et al.]". Berlin & Würzburg....
- [4] Pentixapharm AG. (7/3/24). "Press Release: Pentixapharm Acquires Target Discovery Business of Glycotope". Würzburg & Berlin....
- [5] Eckert & Ziegler Strahlen- und Medizintechnik AG. (6/8/23). "Press Release: PentixaPharm Receives BfArM-Clearance for Its Therapeutic to Conduct a Clinical Trial in Lymphoma". Würzburg....
- [6] PentixaPharm GmbH. (2/6/20). "Press Release: PentixaPharm Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics". Würzburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top